These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

799 related articles for article (PubMed ID: 36090054)

  • 1. Classification of stomach adenocarcinoma based on fatty acid metabolism-related genes frofiling.
    Liu C; Tao Y; Lin H; Lou X; Wu S; Chen L
    Front Mol Biosci; 2022; 9():962435. PubMed ID: 36090054
    [No Abstract]   [Full Text] [Related]  

  • 2. A novel endoplasmic reticulum stress-related lncRNA signature for prognosis prediction and immune response evaluation in Stomach adenocarcinoma.
    Song Z; Su M; Li X; Xie J; Han F; Yao J
    BMC Gastroenterol; 2023 Dec; 23(1):432. PubMed ID: 38066437
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatty Acid Metabolism Signature Contributes to the Molecular Diagnosis of a Malignant Gastric Cancer Subtype with Poor Prognosis and Lower Mutation Burden.
    Chen Z; Cheng G
    Recent Pat Anticancer Drug Discov; 2024; 19(5):666-680. PubMed ID: 37691229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Amino acid metabolism-related genes as potential biomarkers and the role of MATN3 in stomach adenocarcinoma: A bioinformatics, mendelian randomization and experimental validation study.
    Zhu W; Fu M; Li Q; Chen X; Liu Y; Li X; Luo N; Tang W; Zhang Q; Yang F; Chen Z; Zhang Y; Peng B; Zhang Q; Zhang Y; Peng X; Hu G
    Int Immunopharmacol; 2024 Dec; 143(Pt 1):113253. PubMed ID: 39353384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel fatty-acid metabolism-based classification for triple negative breast cancer.
    Yang X; Tang W; He Y; An H; Wang J
    Aging (Albany NY); 2023 Feb; 15(4):1177-1198. PubMed ID: 36880837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a fatty acid metabolism-related gene signature to predict prognosis in stomach adenocarcinoma.
    Liu L; Sun J; Zhong C; Zhang A; Wang G; Chen S; Zhang S; Wang M; Li L
    Aging (Albany NY); 2024 May; 16(10):8552-8571. PubMed ID: 38742949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
    Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
    Front Oncol; 2021; 11():612952. PubMed ID: 34235071
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of fatty acid metabolism-related molecular subtype biomarkers and their correlation with immune checkpoints in cutaneous melanoma.
    Xu Y; Chen Y; Jiang W; Yin X; Chen D; Chi Y; Wang Y; Zhang J; Zhang Q; Han Y
    Front Immunol; 2022; 13():967277. PubMed ID: 36466837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constructing a novel gene signature derived from oxidative stress specific subtypes for predicting survival in stomach adenocarcinoma.
    Zhou R; Peng N; Li W
    Front Immunol; 2022; 13():964919. PubMed ID: 36059494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration.
    Wang Z; Cao L; Zhou S; Lyu J; Gao Y; Yang R
    Front Immunol; 2022; 13():854785. PubMed ID: 35392086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction of store-operated calcium entry-related gene signature for predicting prognosis and indicates immune microenvironment infiltration in stomach adenocarcinomas.
    Zhang Z; Wang C; Shi W; Wang Z; Fu W
    Sci Rep; 2024 Sep; 14(1):22342. PubMed ID: 39333689
    [TBL] [Abstract][Full Text] [Related]  

  • 14. UBR1 is a prognostic biomarker and therapeutic target associated with immune cell infiltration in gastric cancer.
    Yuan W; Han J; Chen C; Qiu Y; Xu Y; Huang Y; Chen Z; Xu A; Sun M
    Aging (Albany NY); 2024 Aug; 16(16):12029-12049. PubMed ID: 39181686
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
    Liu Z; Liu H; Wang Y; Li Z
    BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Characterization of Transforming Growth Factor Beta Receptor 1 in Stomach Adenocarcinoma Identifies a Prognostic Signature for Predicting Clinical Outcomes and Immune Infiltrates.
    He Y; Zhang H; Zhang Y; Wang P; Zhu K; Ba Y
    Int J Gen Med; 2022; 15():3375-3391. PubMed ID: 35368798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a novel copper metabolism-related risk model to predict prognosis and tumor microenvironment of patients with stomach adenocarcinoma.
    Sun D; Zhang H; Zhang C
    Front Pharmacol; 2023; 14():1185418. PubMed ID: 37284310
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytokine-Like Protein 1 (CYTL1) as a Key Target of M-Stage Immune Infiltration in Stomach Adenocarcinoma.
    Zhou F; Lin Q; Zheng Z
    Biomed Res Int; 2023; 2023():2926218. PubMed ID: 36825034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of an immunogenic cell death prognostic signature for predicting clinical outcome and immune infiltration characterization in stomach adenocarcinoma.
    Liu Y; Zhang L; Lei X; Yin X; Liu S
    Aging (Albany NY); 2023 Oct; 15(20):11389-11411. PubMed ID: 37862109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.